Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$3.16B |
| 2 |
Merck
MRK
|
+$2.72B |
| 3 |
SLB Ltd
SLB
|
+$1.62B |
| 4 |
Target
TGT
|
+$1.6B |
| 5 |
General Mills
GIS
|
+$930M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.81B |
| 2 |
Blackrock
BLK
|
+$2.57B |
| 3 |
US Bancorp
USB
|
+$1.84B |
| 4 |
M&T Bank
MTB
|
+$808M |
| 5 |
Huntington Bancshares
HBAN
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.45% |
| 2 | Financials | 11.9% |
| 3 | Healthcare | 10.6% |
| 4 | Consumer Discretionary | 9.01% |
| 5 | Industrials | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Pitney Bowes
PBI
$2.39B
| $15.6M | ﹤0.01% |
1,726,734
-569,531
| -25% | -$5.16M |
|
1752
Astrana Health
ASTH
$1.77B
| $15.5M | ﹤0.01% |
499,529
+28,200
| +6% | +$939K |
|
1753
Harmony Biosciences
HRMY
$2.24B
| $15.5M | ﹤0.01% |
466,072
-5,956
| -1% | -$214K |
|
1754
Enact Holdings
ACT
$6.83B
| $15.5M | ﹤0.01% |
444,914
+61,751
| +16% | +$2.06M |
|
1755
Progyny
PGNY
$2.2B
| $15.4M | ﹤0.01% |
689,443
+51,810
| +8% | +$1.12M |
|
|
VISN
1756
Vistance Networks Inc
VISN
$2.52B
| $15.3M | ﹤0.01% |
2,889,819
-384,056
| -12% | -$2.04M |
|
1757
Trump Media & Technology Group
DJT
$2.83B
| $15.3M | ﹤0.01% |
785,217
-3,505
| -0.4% | -$98.4K |
|
1758
Alignment Healthcare
ALHC
$2.98B
| $15.3M | ﹤0.01% |
823,158
-24,816
| -3% | -$370K |
|
1759
Forward Air
FWRD
$654M
| $15.3M | ﹤0.01% |
761,231
+5,388
| +0.7% | +$149K |
|
|
SLNO
1760
DELISTED
Soleno Therapeutics
SLNO
| $15.3M | ﹤0.01% |
213,984
-3,566
| -2% | -$174K |
|
1761
Rocket Companies
RKT
$38.8B
| $15.3M | ﹤0.01% |
1,266,399
+103,156
| +9% | +$1.33M |
|
1762
SharkNinja
SN
$26.1B
| $15.2M | ﹤0.01% |
181,888
-26,024
| -13% | -$2.65M |
|
1763
Beam Therapeutics
BEAM
$2.84B
| $15.2M | ﹤0.01% |
776,445
+127,500
| +20% | +$3.34M |
|
1764
Vertex
VERX
$1.94B
| $15.2M | ﹤0.01% |
432,810
-5,929
| -1% | -$271K |
|
1765
nCino
NCNO
$2.1B
| $15.2M | ﹤0.01% |
551,585
-15,042
| -3% | -$476K |
|
1766
Marten Transport
MRTN
$1.22B
| $15.1M | ﹤0.01% |
1,099,809
+75,692
| +7% | +$1.13M |
|
1767
Stock Yards Bancorp
SYBT
$2.6B
| $15.1M | ﹤0.01% |
218,258
-4,374
| -2% | -$314K |
|
1768
Azenta
AZTA
$1.48B
| $15M | ﹤0.01% |
434,341
-27,262
| -6% | -$1.25M |
|
|
DVAX
1769
DELISTED
Dynavax Technologies
DVAX
| $15M | ﹤0.01% |
1,157,993
+2,913
| +0.3% | +$38.5K |
|
1770
Tarsus Pharmaceuticals
TARS
$2.84B
| $14.9M | ﹤0.01% |
290,318
-3,382
| -1% | -$167K |
|
|
RDUS
1771
DELISTED
Radius Recycling
RDUS
| $14.9M | ﹤0.01% |
515,899
+175,615
| +52% | +$2.83M |
|
1772
Lufax Holding
LU
$1.3B
| $14.9M | ﹤0.01% |
5,011,130
+805,292
| +19% | +$2.23M |
|
1773
JELD-WEN Holding
JELD
$164M
| $14.9M | ﹤0.01% |
2,489,949
+264,510
| +12% | +$1.96M |
|
1774
TFI International
TFII
$11.5B
| $14.8M | ﹤0.01% |
191,770
-3,579
| -2% | -$396K |
|
1775
Amneal Pharmaceuticals
AMRX
$5.79B
| $14.8M | ﹤0.01% |
1,767,594
+227,660
| +15% | +$1.9M |
|
Similar funds
Charles Schwab's Q1 2025 Portfolio in Review
As of Q1 2025, Charles Schwab held 3,548 positions worth $533B, down 1.7% from $542B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 3.6%. Charles Schwab opened 55 new positions and exited 74, leaving the 3,548-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2025 buy was iShares Currency Hedged MSCI Eurozone ETF: 7,259,426 shares worth $283M.
- Charles Schwab added most to ConocoPhillips in Q1 2025, an estimated $3.16B increase.
- Charles Schwab's biggest Q1 2025 reduction was Pfizer, cutting an estimated $2.81B.
- Charles Schwab fully exited Brookfield in Q1 2025, selling an estimated $218M.
- Charles Schwab's ten largest holdings make up 20% of its $533B portfolio in Q1 2025.
- Charles Schwab opened 55 new positions and closed 74 in Q1 2025.
- Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $533B.
Based on Charles Schwab's 13F filing for Q1 2025, filed 9 May 2025.